Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burger

Showing results (971-980 of 1,155) with videos related to

Pageof 116
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2014
American Society of Clinical Oncology position statement on obesity and cancerJennifer A Ligibel, Catherine M Alfano, Kerry S Courneya, et al.
Haematologica|June 9, 2018
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2Paul M Barr, Tadeusz Robak, Carolyn Owen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 19, 2017
Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling StudyCarolyn M Rutter, Jane J Kim, Reinier G S Meester, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer IntergroupMichael A Bookman, Mark F Brady, William P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A Wright, Angel Cronin, Dana E Milne, et al.
Cancer|August 27, 2015
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaFarhad Ravandi, Susan M O'Brien, Jorge E Cortes, et al.
Blood|December 12, 2018
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemiaJan A Burger, Mariela Sivina, Nitin Jain, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2025
Implications of inaccurate lymph node staging in early and intermediate-risk rectal cancer on survival-related outcomes in a large Dutch population-based cohortF E C Vande Kerckhove, K van den Berg, F N van Erning, et al.
Pageof 116

Showing results (971-980 of 1,155) with videos related to

Sort By:
Pageof 116
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2014
American Society of Clinical Oncology position statement on obesity and cancerJennifer A Ligibel, Catherine M Alfano, Kerry S Courneya, et al.
Haematologica|June 9, 2018
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2Paul M Barr, Tadeusz Robak, Carolyn Owen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 19, 2017
Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling StudyCarolyn M Rutter, Jane J Kim, Reinier G S Meester, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer IntergroupMichael A Bookman, Mark F Brady, William P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A Wright, Angel Cronin, Dana E Milne, et al.
Cancer|August 27, 2015
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaFarhad Ravandi, Susan M O'Brien, Jorge E Cortes, et al.
Blood|December 12, 2018
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemiaJan A Burger, Mariela Sivina, Nitin Jain, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2025
Implications of inaccurate lymph node staging in early and intermediate-risk rectal cancer on survival-related outcomes in a large Dutch population-based cohortF E C Vande Kerckhove, K van den Berg, F N van Erning, et al.
Pageof 116